Pediatric non–Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes
Nature Genetics2017Vol. 49(3), pp. 451–456
Citations Over TimeTop 10% of 2017 papers
Jasmijn de Rooij, Cristyn Branstetter, Jing Ma, Yongjin Li, Michael Walsh, Jinjun Cheng, Askar Obulkasim, Jinjun Dang, John Easton, Lonneke Verboon, Heather L. Mulder, Martin Zimmermann, Cary Koss, Pankaj Gupta, Michael N. Edmonson, Michael Rusch, Joshua Yew Suang Lim, Katarina Reinhardt, Martina Pigazzi, Guangchun Song, Allen Eng Juh Yeoh, Lee‐Yung Shih, Der-Cherng Liang, Stephanie Halene, Diane S. Krause, Jinghui Zhang, James R. Downing, Franco Locatelli, Dirk Reinhardt, Marry M. van den Heuvel‐Eibrink, C. Michel Zwaan, Maarten Fornerod, Tanja A. Grüber
Related Papers
- → GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome(2003)324 cited
- → Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi‐step model of myeloid leukaemogenesis(2009)126 cited
- → Acute megakaryoblastic leukemia in Down syndrome(2007)28 cited
- → Transient Myeloproliferative Disorder and GATA1 Mutation in Neonates With and Without Down Syndrome(2011)19 cited
- → Evolution of myeloid leukemia in children with Down syndrome(2016)16 cited